Michael H. Carrel is the President and Chief Executive Officer at ATRICURE INC, a leading medical device company specializing in innovative solutions for the treatment of atrial fibrillation and related conditions. With a robust background in the healthcare industry, Carrel has been instrumental in steering ATRICURE INC towards significant growth and development. Prior to joining ATRICURE INC, he held various leadership positions at other prominent medical technology companies, where he honed his skills in strategic planning, operational excellence, and market expansion. At ATRICURE INC, Carrel has been pivotal in driving the company's mission to improve the quality of life for patients suffering from atrial fibrillation. Under his leadership, the company has successfully expanded its product portfolio and enhanced its global presence. Carrel's strategic vision has led to the development of cutting-edge technologies and the establishment of strong partnerships within the medical community. His commitment to innovation and patient care has been recognized through numerous industry awards and accolades, further solidifying ATRICURE INC's position as a leader in the field. In addition to his role at ATRICURE INC, Michael H. Carrel is actively involved in various professional and community organizations, where he advocates for advancements in healthcare and supports initiatives aimed at improving patient outcomes. His leadership style, characterized by a blend of technical expertise and empathetic management, has fostered a collaborative and dynamic work environment at ATRICURE INC. Carrel's dedication to the company's mission and his ability to navigate the complex landscape of medical technology continue to drive ATRICURE INC's success and growth.